Skip to main content
Caplight Logo









Delta Biosciences

Delta Biosciences

Private
VilniusFrontier & Industrial Techhttps://www.deltabiosciences.com/

Last Round

Accelerator

May 5, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Delta Biosciences is a biotechnology company that develops next-generation pharmaceuticals and biochemical formulations for medicinal and space chemistry applications.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Space Technology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

space-as-a-servicemicrogravity researchpharmaceutical stabilityradioprotective compoundsin-orbit experimentationspace pharmapayload developmentdrug discoveryradio-resistant excipientsspace biotechmission designdegradation profilingcomputational drug designspace infrastructurehigh-throughput screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delta Biosciences Comparables

Compare Delta Biosciences with similar companies based on industry and business-model similarity.

Delta Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Yuri
86%
Frontier Space Technologies
84%
SpacePharma
83%

Delta Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 5, 2026
AcceleratorSep 24, 2024

Delta Biosciences Investors

Notable investors and investment history

Delta Biosciences investors
InvestorRounds
Starburst AerospaceAccelerator
CASSINI Business AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2026

    Received funding from CASSINI Business Accelerator.

  • Sep 24, 2024

    Received funding from Starburst Aerospace.

Delta Biosciences Filings

Explore SEC and related filing metadata, where available.

Delta Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Delta Biosciences's valuation, stock price, and market status.

Is Delta Biosciences a public or private company?

Delta Biosciences is a private company.

What is the current stock price of Delta Biosciences?

Delta Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Delta Biosciences worth (valuation)?

Valuation information for Delta Biosciences is not publicly available.

Can I buy Delta Biosciences stock?

Delta Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Delta Biosciences's last funding round?

Delta Biosciences's most recent funding round was Accelerator on May 5, 2026.

Who are the main investors in Delta Biosciences?

Key investors in Delta Biosciences include Starburst Aerospace, CASSINI Business Accelerator.

Will Delta Biosciences IPO soon?

No public IPO plans have been announced for Delta Biosciences.

How can I track Delta Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Delta Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVilnius
Employee Range7
Year Founded2020
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?